NCT00218231View on ClinicalTrials.gov

Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
SchizophreniaTobacco Use Disorder
Interventions
DRUG

300 mg/day bupropion-sr

300 mg/day for 1 week

DRUG

0 mg/day bupropion-sr

0 mg/day bupropion-sr

Trial Locations (2)

02908

Providence VA Medical Center, RI, Providence

02912

Brown University, Providence

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00218231 - Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia | Biotech Hunter | Biotech Hunter